Why is Supriya Lifescience Ltd ?
1
High Management Efficiency with a high ROE of 17.74%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
Poor long term growth as Net Sales has grown by an annual rate of 12.89% and Operating profit at 7.16% over the last 5 years
4
Flat results in Sep 25
5
With ROE of 18.3, it has a Very Expensive valuation with a 6.1 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -6.69%, its profits have risen by 15.8% ; the PEG ratio of the company is 2.1
6
Falling Participation by Institutional Investors
- Institutional investors have decreased their stake by -0.96% over the previous quarter and collectively hold 10.68% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Supriya Lifesci. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Supriya Lifesci.
-22.5%
-0.15
44.74%
Sensex
-4.3%
0.44
11.83%
Quality key factors
Factor
Value
Sales Growth (5y)
11.47%
EBIT Growth (5y)
5.52%
EBIT to Interest (avg)
81.39
Debt to EBITDA (avg)
0.18
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
0.70
Tax Ratio
24.90%
Dividend Payout Ratio
4.28%
Pledged Shares
0
Institutional Holding
10.21%
ROCE (avg)
28.52%
ROE (avg)
17.74%
Valuation Key Factors 
Factor
Value
P/E Ratio
26
Industry P/E
31
Price to Book Value
4.93
EV to EBIT
20.32
EV to EBITDA
18.32
EV to Capital Employed
5.24
EV to Sales
6.58
PEG Ratio
4.15
Dividend Yield
0.16%
ROCE (Latest)
26.04%
ROE (Latest)
18.62%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Technical Movement
1What is working for the Company
NET SALES(Q)
Highest at Rs 206.44 cr
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Supriya Lifesci.
Net Sales - Quarterly
Highest at Rs 206.44 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)